Canada markets closed

Ultimovacs ASA (7UM.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
0.80900.0000 (0.00%)
At close: 08:08AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
123,062
123,834
95,175
96,735
64,660
-
Selling General and Administrative
7,465
6,476
9,246
5,061
3,978
-
Total Operating Expenses
191,966
215,733
183,629
163,832
124,146
-
Operating Income or Loss
-193,619
-215,733
-183,629
-163,832
-124,146
-
Interest Expense
-
-
-
333
240
263
Income Before Tax
-177,880
-189,239
-167,792
-164,722
-120,552
-
Income Tax Expense
0
0
0
0
0
-
Income from Continuing Operations
-177,880
-189,239
-167,792
-164,722
-120,552
-
Net Income
-177,880
-189,239
-167,792
-164,722
-120,552
-
Net Income available to common shareholders
-177,880
-189,239
-167,792
-164,722
-120,552
-
Basic EPS
-6.00
-5.50
-4.90
-5.10
-4.00
-
Diluted EPS
-6.00
-5.50
-4.90
-5.10
-4.00
-
Basic Average Shares
34,374
34,398
34,247
32,373
30,260
-
Diluted Average Shares
34,374
34,398
34,247
32,373
30,260
-